Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN) has a 23-report earnings history dating back to Nov 05, 2020. Its average absolute post-earnings move is ±4.73%, and 69.6% of those reactions were positive. Its largest post-earnings gain was +20.16% (May 08, 2025) and its largest decline was -12.89% (Nov 05, 2025). The next earnings report is predicted for 2026-08-13 (approximate).
Earnings reactions
How DYN moved on each past earnings report.
Earnings Impact
Total Earnings
23
Avg Abs. Movement
±4.73%
Positive %
69.6%
Negative %
30.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 11, 2026 | ☀ PRE | +4.71% | open_in_new |
| Mar 02, 2026 | ☀ PRE | +3.39% | open_in_new |
| Nov 05, 2025 | ☽ POST | -12.89% | open_in_new |
| Jul 28, 2025 | ☽ POST | -1.18% | open_in_new |
Earnings Count
23
Total earnings in dataset
Avg Abs. Movement
±4.73%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 424B5 | 20260722 | open_in_new SEC.gov |
| 8-K | 20260722 | open_in_new SEC.gov |
| 424B5 | 20260721 | open_in_new SEC.gov |
| 8-K | 20260720 | open_in_new SEC.gov |
| 4 | 20260708 | open_in_new SEC.gov |
| 144 | 20260707 | open_in_new SEC.gov |
| 144 | 20260707 | open_in_new SEC.gov |
| 144 | 20260707 | open_in_new SEC.gov |
| 144 | 20260707 | open_in_new SEC.gov |
| 144 | 20260706 | open_in_new SEC.gov |
Frequently asked about DYN earnings
When does Dyne Therapeutics, Inc. report earnings next? expand_more
Dyne Therapeutics, Inc. (DYN)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DYN stock move after earnings? expand_more
Over 23 reports, DYN has moved an average of ±4.73% the session after earnings, closing higher 69.6% of the time.
What was DYN's biggest post-earnings move? expand_more
DYN's largest post-earnings gain on record was +20.16% on May 08, 2025, and its largest decline was -12.89% on Nov 05, 2025.
Where can I find Dyne Therapeutics, Inc.'s SEC filings? expand_more
All of Dyne Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right